{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:11:41Z","timestamp":1778645501212,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014454","name":"Leonard M. Miller School of Medicine, University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014454","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007826","name":"American Glaucoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["UL1TR002736"],"award-info":[{"award-number":["UL1TR002736"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ajo.2020.10.004","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T11:05:35Z","timestamp":1602327935000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Factors Associated With Favorable Laser Trabeculoplasty Response: IRIS Registry Analysis"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4827-5014","authenticated-orcid":false,"given":"Ta C.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4116-8657","authenticated-orcid":false,"given":"Danielle","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1875-4524","authenticated-orcid":false,"given":"Elizabeth A.","family":"Vanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajo.2020.10.004_bib1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.ophtha.2015.04.015","article-title":"Use of various glaucoma surgeries and procedures in medicare beneficiaries from 1994 to 2012","volume":"122","author":"Arora","year":"2015","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2020.10.004_bib2","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0161-6420(98)91129-0","article-title":"Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study","volume":"105","author":"Latina","year":"1998","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2020.10.004_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/bjo.83.6.718","article-title":"Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial","volume":"83","author":"Damji","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2020.10.004_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archopht.121.7.957","article-title":"Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study","volume":"121","author":"Melamed","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2020.10.004_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1034\/j.1600-0420.1999.770212.x","article-title":"The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma","volume":"77","author":"Odberg","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"10.1016\/j.ajo.2020.10.004_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00061198-200604000-00009","article-title":"Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma","volume":"15","author":"McIlraith","year":"2006","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2020.10.004_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2147\/OPTH.S19873","article-title":"Predictive factors of success in selective laser trabeculoplasty (SLT) treatment","volume":"5","author":"Ayala","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2020.10.004_bib8","doi-asserted-by":"crossref","first-page":"642869","DOI":"10.1155\/2012\/642869","article-title":"Baseline factors predictive of SLT response: a prospective study","volume":"2012","author":"Bruen","year":"2012","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2020.10.004_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12886-016-0385-z","article-title":"Selective laser trabeculoplasty for early glaucoma: analysis of success predictors and adjusted laser outcomes based on the untreated fellow eye","volume":"16","author":"Chun","year":"2016","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.10.004_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0034-1368218","article-title":"Long-term efficacy of selective laser trabeculoplasty in patients on prostaglandin therapy","volume":"231","author":"Hirn","year":"2014","journal-title":"Klin Monbl Augenheilkd"},{"issue":"9","key":"10.1016\/j.ajo.2020.10.004_bib11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bjo.2004.062414","article-title":"Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial","volume":"89","author":"Hodge","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2020.10.004_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/IJG.0b013e31815f52cb","article-title":"Development of a prediction rule to estimate the probability of acceptable intraocular pressure reduction after selective laser trabeculoplasty in open-angle glaucoma and ocular hypertension","volume":"17","author":"Mao","year":"2008","journal-title":"J Glaucoma"},{"issue":"4","key":"10.1016\/j.ajo.2020.10.004_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/IJG.0b013e3181e3d2c1","article-title":"SLT and adjunctive medical therapy: a prediction rule analysis","volume":"20","author":"Martow","year":"2011","journal-title":"J Glaucoma"},{"issue":"7","key":"10.1016\/j.ajo.2020.10.004_bib14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/IJG.0000000000001250","article-title":"West Indies Glaucoma Laser Study (WIGLS) 3. Anterior Chamber Inflammation Following Selective Laser Trabeculoplasty in Afro-Caribbeans with Open-angle Glaucoma","volume":"28","author":"Realini","year":"2019","journal-title":"Journal of Glaucoma"},{"issue":"5","key":"10.1016\/j.ajo.2020.10.004_bib15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.ijg.0000176939.43681.c2","article-title":"High failure rate associated with 180 degrees selective laser trabeculoplasty","volume":"14","author":"Song","year":"2005","journal-title":"J Glaucoma"},{"issue":"10","key":"10.1016\/j.ajo.2020.10.004_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamaophthalmol.2016.2495","article-title":"Comparison of outcomes of laser trabeculoplasty performed by optometrists vs ophthalmologists in Oklahoma","volume":"134","author":"Stein","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2020.10.004_bib17","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ophtha.2017.12.001","article-title":"The 2016 American Academy of Ophthalmology IRIS \u00ae Registry (Intelligent Research in Sight) database: characteristics and methods","volume":"125","author":"Chiang","year":"2018","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2020.10.004_bib18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ophtha.2017.02.018","article-title":"Treatment patterns for myopic choroidal neovascularization in the United States: analysis of the IRIS registry","volume":"124","author":"Willis","year":"2017","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2020.10.004_bib19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ophtha.2017.10.010","article-title":"Real-World vision in age-related macular degeneration patients treated with single anti-VEGF drug type for 1 year in the IRIS registry","volume":"125","author":"Rao","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2020.10.004_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.preteyeres.2017.12.002","article-title":"Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors","volume":"65","author":"Mehta","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.ajo.2020.10.004_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ophtha.2017.11.027","article-title":"The real-World effect of intravitreous anti-vascular endothelial growth factor drugs on intraocular pressure: an analysis using the IRIS registry","volume":"125","author":"Atchison","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2020.10.004_bib22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2018.01.009","article-title":"Return to the operating room after macular surgery: IRIS registry analysis","volume":"125","author":"Parke","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2020.10.004_bib23","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.ophtha.2018.04.024","article-title":"Strabismus, strabismus surgery, and reoperation rate in the United States: analysis from the IRIS registry","volume":"125","author":"Repka","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2020.10.004_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ophtha.2019.08.026","article-title":"Endophthalmitis after cataract surgery in the United States: a report from the intelligent research in sight registry, 2013-2017","volume":"127","author":"Pershing","year":"2020","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2020.10.004_bib25","doi-asserted-by":"crossref","first-page":"e110403","DOI":"10.1371\/journal.pone.0110403","article-title":"Results of observational studies: analysis of findings from the Nurses' Health Study","volume":"9","author":"Tai","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajo.2020.10.004_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1245\/s10434-007-9658-3","article-title":"Limitations of claims and registry data in surgical oncology research","volume":"15","author":"Nathan","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ajo.2020.10.004_bib27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/112067210501500507","article-title":"Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: Strategies, clinical outcomes, and costs at 2 years","volume":"15","author":"Rouland","year":"2005","journal-title":"Eur J Ophthalmol"},{"issue":"Suppl 4","key":"10.1016\/j.ajo.2020.10.004_bib28","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/112067210301304S02","article-title":"Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: strategies, clinical outcomes, and costs at 1 year","volume":"13","author":"Rouland","year":"2003","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.10.004_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00019053-200725040-00003","article-title":"The economic implications of glaucoma: a literature review","volume":"25","author":"Schmier","year":"2007","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.ajo.2020.10.004_bib30","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1185\/03007990802379996","article-title":"Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US","volume":"24","author":"Cantor","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.ajo.2020.10.004_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF02850198","article-title":"Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: evaluation of brimonidine as a model","volume":"18","author":"Abelson","year":"2001","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.ajo.2020.10.004_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2005.10.034","article-title":"Patient-reported behavior and problems in using glaucoma medications","volume":"113","author":"Sleath","year":"2006","journal-title":"Ophthalmology"},{"issue":"11 Suppl","key":"10.1016\/j.ajo.2020.10.004_bib33","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ophtha.2009.06.024","article-title":"A comprehensive perspective on patient adherence to topical glaucoma therapy","volume":"116","author":"Tsai","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2020.10.004_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5301\/EJO.2010.6112","article-title":"Do adherence rates and glaucomatous visual field progression correlate?","volume":"21","author":"Rossi","year":"2011","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2020.10.004_bib35","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.ophtha.2011.05.013","article-title":"The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity","volume":"118","author":"Sleath","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2020.10.004_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","article-title":"The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study","volume":"127","author":"Newman Casey","year":"2020","journal-title":"Ophthalmology"},{"issue":"10180","key":"10.1016\/j.ajo.2020.10.004_bib37","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajo.2020.10.004_bib38","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ophtha.2019.11.017","article-title":"Real-world outcomes of selective laser trabeculoplasty in the United Kingdom","volume":"127","author":"Khawaja","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2020.10.004_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jamaophthalmol.2013.1706","article-title":"Selective laser trabeculoplasty for the management of open-angle glaucoma in St. Lucia","volume":"131","author":"Realini","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2020.10.004_bib40","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ophtha.2011.04.037","article-title":"Laser trabeculoplasty for open-angle glaucoma: a report by the American Academy of Ophthalmology","volume":"118","author":"Samples","year":"2011","journal-title":"Ophthalmology"},{"issue":"31","key":"10.1016\/j.ajo.2020.10.004_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23310","article-title":"Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT","volume":"23","author":"Gazzard","year":"2019","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.ajo.2020.10.004_bib42","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0002-9394(14)72725-4","article-title":"The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Glaucoma Laser Trial Research Group","volume":"120","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.10.004_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archophthalmol.2011.2727","article-title":"Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma","volume":"130","author":"Stein","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2020.10.004_bib44","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ophtha.2019.04.012","article-title":"Primary selective laser trabeculoplasty for open-angle glaucoma and ocular hypertension: clinical outcomes, predictors of success, and safety from the laser in glaucoma and ocular hypertension trial","volume":"126","author":"Garg","year":"2019","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2020.10.004_bib45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/bjophthalmol-2019-315489","article-title":"Predictors of selective laser trabeculoplasty success in open angle glaucoma or ocular hypertension: does baseline tonography have a predictive role?","volume":"104","author":"Alaghband","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2020.10.004_bib46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/aos.13094","article-title":"Preoperative intraocular pressure as a predictor of selective laser trabeculoplasty efficacy","volume":"94","author":"Pillunat","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2020.10.004_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000074562","article-title":"One-year follow-up of selective laser trabeculoplasty in open-angle glaucoma","volume":"218","author":"Cvenkel","year":"2004","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.ajo.2020.10.004_bib48","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1442-9071.2004.00839.x","article-title":"Five-year follow up of selective laser trabeculoplasty in Chinese eyes","volume":"32","author":"Lai","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.10.004_bib49","first-page":"267","article-title":"[Selective laser trabeculoplasty]","volume":"60","author":"Rozsival","year":"2004","journal-title":"Cesk Slov Oftalmol"},{"issue":"3","key":"10.1016\/j.ajo.2020.10.004_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1442-9071.1985.tb00430.x","article-title":"Argon laser trabeculoplasty and the open-angle glaucomas","volume":"13","author":"Goldberg","year":"1985","journal-title":"Aust N Z J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2020.10.004_bib51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archopht.1983.01040010382005","article-title":"Argon laser trabeculoplasty in secondary forms of open-angle glaucoma","volume":"101","author":"Robin","year":"1983","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2020.10.004_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3928\/1542-8877-19970301-07","article-title":"Efficacy of argon laser trabeculoplasty in aphakic and pseudophakic eyes","volume":"28","author":"Schwartz","year":"1997","journal-title":"Ophthal Surg Lasers"},{"issue":"7","key":"10.1016\/j.ajo.2020.10.004_bib53","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/s41433-018-0059-6","article-title":"Trabeculectomy training in England: are we safe at training? Two year surgical outcomes","volume":"32","author":"Walkden","year":"2018","journal-title":"Eye (Lond)"},{"issue":"11","key":"10.1016\/j.ajo.2020.10.004_bib54","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/IJG.0000000000000775","article-title":"Primary trabeculectomy outcomes by glaucoma fellows in a tertiary hospital in Brazil","volume":"26","author":"Abe","year":"2017","journal-title":"J Glaucoma"},{"issue":"5","key":"10.1016\/j.ajo.2020.10.004_bib55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3928\/15428877-20100625-01","article-title":"Trainee glaucoma surgery: experience with trabeculectomy and glaucoma drainage devices","volume":"41","author":"Connor","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ajo.2020.10.004_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajo.2017.09.022","article-title":"West Indies Glaucoma Laser Study (WIGLS): 1. 12-month efficacy of selective laser trabeculoplasty in afro-caribbeans with glaucoma","volume":"184","author":"Realini","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2020.10.004_bib57","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamaophthalmol.2014.369","article-title":"Trends over time and regional variations in the rate of laser trabeculoplasty in the Medicare population","volume":"132","author":"Jampel","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2020.10.004_bib58","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/s41433-019-0452-9","article-title":"Glaucoma surgery preferences when the surgeon adopts the role of the patient","volume":"33","author":"Chang","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2020.10.004_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2415-15-1","article-title":"Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942030564X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942030564X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:30:03Z","timestamp":1778643003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293942030564X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":59,"alternative-id":["S000293942030564X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2020.10.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738834086.793584976","asserted-by":"object"}]},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Associated With Favorable Laser Trabeculoplasty Response: IRIS Registry Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2020.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}